title: Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma.
authors: Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.
authors: Christopher J
authors: CJ
authors: Anker
authors: Antoni
authors: A
authors: Ribas
authors: Allie H
authors: AH
authors: Grossmann
authors: Xinjian
authors: X
authors: Chen
authors: Krishna K
authors: KK
authors: Narra
authors: Wallace
authors: W
authors: Akerley
authors: Robert H I
authors: RH
authors: Andtbacka
authors: Robert Dirk
authors: RD
authors: Noyes
authors: Dennis C
authors: DC
authors: Shrieve
authors: Kenneth F
authors: KF
authors: Grossmann
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008197:Lymph Node Excision; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D009362:Neoplasm Metastasis; D011832:Radiation Injuries / Q000209:etiology*; D012871:Skin Diseases / Q000139:chemically induced / Q000209:etiology*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib